Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer

作者
Jinhui Che,Zhiyuan Chen,Feng Zhang,Shuo Zhu,Shengya Cao,Ou Li,Rong Li,Jun Zheng,Yubin Liu
出处
期刊:Oncology Research [Cognizant Communication Corporation]
卷期号:34 (7): 1-10
标识
DOI:10.32604/or.2026.067443
摘要

Drug resistance limits the therapeutic effects of multi-kinase inhibitor, sorafenib, for patients with advanced stage liver cancer. Aberrant mitochondrial dynamics and metabolism are now considered hallmarks of liver tumors. Thus, the present study was to clarify the relationship between mitochondrial dynamics and metabolism, and explore the combination of targeting therapies for sorafenib-resistant liver cancer. Mitochondrial metabolism switch was evaluated by oxygen consumption ratio, glucose uptake and lactate production. Cell counting, colony formation, cell cycle assays, time-lapse cell motility and Transwell assays were used to evaluate cell growth, migration and invasion capacities. Orthotopic xenograft models were used to illustrate the therapeutic effects of the combined administration of the oxidative phosphorylation (OXPHOS) inhibitor, IACS-010759, with the Drp1 inhibitor, mdivi-1. In the present study, Drp1-mediated mitochondrial fission and the hyper-glycolytic phenotype were dominant in sorafenib-resistant liver cancer cells, which were closely correlated with tumor prognosis. Drp1 knockdown or inhibition impaired the invasive and metastatic capacities of cancer cells, but promoted cell cycle and cellular growth, which was due to the metabolic shift from aerobic glycolysis to OXPHOS. Additional administration of the OXPHOS inhibitor, IACS-010759, combined with the Drp1 inhibitor, mdivi-1, alleviated the tumor progression of sorafenib-resistant liver cancer markedly, both in terms of proliferation and metastasis. The findings of the current study indicated that mitochondrial dynamics had an impact on mitochondrial metabolism in sorafenib-resistant liver cancer cells. Consequently, the combined targeting of mitochondrial dynamics and metabolism might be an effective way to overcome sorafenib resistance in liver cancer.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
极限001的应助被快乐的心情采纳,获得80
刚刚
1秒前
sakura发布了新的文献求助20
1秒前
water1201发布了新的文献求助10
1秒前
1秒前
FashionBoy的应助被qian采纳,获得10
2秒前
3秒前
小米粥发布了新的文献求助10
3秒前
waiting完成签到,获得积分10
3秒前
3秒前
小马甲的应助被菜黎明采纳,获得10
4秒前
有点意思发布了新的文献求助10
4秒前
bubble发布了新的文献求助10
4秒前
小蘑菇的应助被qq采纳,获得10
4秒前
yeu103325完成签到,获得积分10
4秒前
YB8BALL发布了新的文献求助30
5秒前
5秒前
SciGPT的应助被哦哦哦噢噢噢噢采纳,获得10
5秒前
林林完成签到,获得积分10
6秒前
tcklikai发布了新的文献求助20
6秒前
wkk完成签到,获得积分10
6秒前
马勒的小号发布了新的文献求助100
6秒前
JIE完成签到,获得积分10
6秒前
tao完成签到 ,获得积分10
6秒前
Nora发布了新的文献求助10
8秒前
8秒前
Atheist的应助被xhy采纳,获得10
8秒前
cbx发布了新的文献求助10
8秒前
义气的中恶完成签到 ,获得积分10
9秒前
Yola完成签到,获得积分10
9秒前
无私媚颜完成签到,获得积分10
9秒前
10秒前
10秒前
10秒前
熹光发布了新的文献求助10
11秒前
shuimenw完成签到,获得积分10
12秒前
星许完成签到 ,获得积分10
13秒前
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817